- Home
- PFBC vs ARQT Comparison
PFBC vs ARQT Comparison
Compare PFBC & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFBC
- ARQT
- Stock Information
- Founded
- PFBC 1991
- ARQT 2016
- Country
- PFBC United States
- ARQT United States
- Employees
- PFBC N/A
- ARQT N/A
- Industry
- PFBC Major Banks
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- PFBC Finance
- ARQT Health Care
- Exchange
- PFBC Nasdaq
- ARQT Nasdaq
- Market Cap
- PFBC 1.2B
- ARQT 1.1B
- IPO Year
- PFBC 1998
- ARQT 2020
- Fundamental
- Price
- PFBC $85.96
- ARQT $14.99
- Analyst Decision
- PFBC Buy
- ARQT Strong Buy
- Analyst Count
- PFBC 2
- ARQT 4
- Target Price
- PFBC $99.50
- ARQT $15.50
- AVG Volume (30 Days)
- PFBC 84.1K
- ARQT 2.2M
- Earning Date
- PFBC 01-22-2025
- ARQT 11-06-2024
- Dividend Yield
- PFBC 3.26%
- ARQT N/A
- EPS Growth
- PFBC N/A
- ARQT N/A
- EPS
- PFBC 9.99
- ARQT N/A
- Revenue
- PFBC $260,387,999.00
- ARQT $138,708,000.00
- Revenue This Year
- PFBC N/A
- ARQT $208.32
- Revenue Next Year
- PFBC N/A
- ARQT $48.56
- P/E Ratio
- PFBC $8.60
- ARQT N/A
- Revenue Growth
- PFBC N/A
- ARQT 182.84
- 52 Week Low
- PFBC $66.88
- ARQT $2.60
- 52 Week High
- PFBC $99.78
- ARQT $15.77
- Technical
- Relative Strength Index (RSI)
- PFBC 33.01
- ARQT 67.53
- Support Level
- PFBC $90.71
- ARQT $12.66
- Resistance Level
- PFBC $93.26
- ARQT $15.02
- Average True Range (ATR)
- PFBC 2.38
- ARQT 1.11
- MACD
- PFBC -1.28
- ARQT 0.14
- Stochastic Oscillator
- PFBC 12.51
- ARQT 78.92
About PFBC Preferred Bank
Preferred Bank is a commercial bank located in California. Its products and services are divided into Personal Banking, Business Banking, and Commercial Banking which includes Checking accounts, Savings accounts, CDs, Loans and Credit, Electronic banking and Treasury Management. It provides personalized deposit services, real estate finance, commercial loans, and trade finance credit facilities to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals and high-net-worth individuals. The bank generates a majority of its revenue from Southern and Northern California and Flushing.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.